Clinical Trials
18 trialsNCT06162663 2026-02-27
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
Medical University of South Carolina
Phase 4 Terminated
NCT02688803 2025-12-04
OTT15-04
Ottawa Hospital Research Institute
Phase 4 Terminated
NCT05807074 2025-09-29
Impact of Topical Tranexamic Acid in Breast Reconstruction
University of California, San Francisco
Phase 4 Terminated
NCT04657679 2024-11-26
LEANORA
Georgetown University
Phase 4 Terminated
NCT04625517 2023-10-12
Performance of Contrast-Enhanced Spectral Mammography to Assess Neoadjuvant Chemotherapy Response (CEDM)
University of Texas Southwestern Medical Center
Phase 4 Terminated
NCT03220178 2022-01-06
PRECYCLE
Palleos Healthcare GmbH
Phase 4 Terminated
NCT04031885 2021-08-24
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
Eli Lilly and Company
Phase 4 Terminated
NCT02819921 2019-09-20
Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen
Seoul National University Hospital
Phase 4 Terminated
NCT03456661 2019-09-20
Comparison Between Levobupivacaine and Levobupivacaine With Dexmedetomidine in Ultrasound Guided Pectoral Nerve Block
University Hospital, Antwerp
Phase 4 Terminated
NCT00754767 2017-09-11
L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer
HealthPartners Institute
Phase 4 Terminated
NCT00375752 2017-06-26
FEMZONE
Novartis
Phase 4 Terminated
NCT00604968 2017-06-07
Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT00087620 2017-02-03
A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer
Hoffmann-La Roche
Phase 4 Terminated
NCT00779285 2015-07-14
Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT00333229 2014-11-25
A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss
Novartis
Phase 4 Terminated
NCT00699101 2013-06-17
Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy
SenoRx, Inc.
Phase 4 Terminated
NCT00241046 2012-04-19
Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment
Novartis
Phase 4 Terminated
NCT00171847 2010-03-31
eLEcTRA
Novartis
Phase 4 Terminated